89 results
Page 4 of 5
8-K
EX-1.1
rbzha5 47dr7dqmy3g
25 Jun 14
Entry into a Material Definitive Agreement
12:00am
424B5
6u0pb5n1y tkrlkn
23 Jun 14
Prospectus supplement for primary offering
12:00am
424B3
mbm32wifrkneuj3h ng8
29 Jan 14
Prospectus supplement
12:00am
8-K
EX-1.1
4o9428i vj81q
29 Jan 14
Entry into a Material Definitive Agreement
12:00am
424B3
wa5ak4zge3zcn cy
27 Jan 14
Prospectus supplement
12:00am
424B4
1loi5d
3 Oct 13
Prospectus supplement with pricing info
12:00am
S-1/A
EX-1.1
y4bva
30 Sep 13
IPO registration (amended)
12:00am
S-1/A
hy9m9dw ucle
30 Sep 13
IPO registration (amended)
12:00am
S-1
99yy7xrmkj06 8zwrd7j
17 Sep 13
IPO registration
12:00am
8-K
EX-99.1
60l1u8
23 Apr 13
First Patient Dosed in Phase I Study of Prothena’s Therapeutic Antibody for Treatment of AL Amyloidosis
12:00am
10-K
ch9 ydg8yr9nug4
29 Mar 13
Annual report
12:00am
8-K
EX-99.1
95c2g5e5hy01
21 Dec 12
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.2
b6bu6djhh1c qenl
21 Dec 12
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
9rr 9ldjwif
21 Dec 12
Entry into a Material Definitive Agreement
12:00am
10-12B/A
EX-99.1
1w8 1juanva8
17 Dec 12
Registration of securities (amended)
12:00am
10-12B/A
EX-99.1
wuc poycjx
14 Dec 12
Registration of securities (amended)
12:00am